| Primary |
| Pulmonary Arterial Hypertension |
60.0% |
| Pulmonary Hypertension |
14.3% |
| Endocarditis |
5.7% |
| Product Used For Unknown Indication |
5.7% |
| Staphylococcal Infection |
5.7% |
| Connective Tissue Disorder |
2.9% |
| Digital Ulcer |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
|
| Vomiting |
17.4% |
| Fatigue |
8.7% |
| Hypoaesthesia |
8.7% |
| Normal Newborn |
8.7% |
| Biliary Dyskinesia |
4.3% |
| Death |
4.3% |
| Dehydration |
4.3% |
| Fall |
4.3% |
| Haemoglobin Decreased |
4.3% |
| Loss Of Consciousness |
4.3% |
| Nausea |
4.3% |
| Pneumonia |
4.3% |
| Pulmonary Arterial Pressure Increased |
4.3% |
| Red Blood Cell Sedimentation Rate Increased |
4.3% |
| Rickets |
4.3% |
| Staphylococcal Sepsis |
4.3% |
| Weight Increased |
4.3% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
37.0% |
| Pulmonary Hypertension |
26.1% |
| Drug Use For Unknown Indication |
8.1% |
| Nonketotic Hyperglycinaemia |
3.0% |
| Scleroderma |
3.0% |
| Systemic Sclerosis |
3.0% |
| Hiv Infection |
2.5% |
| Product Used For Unknown Indication |
2.3% |
| Eisenmenger's Syndrome |
1.8% |
| Angiopathy |
1.5% |
| Dermatitis Atopic |
1.5% |
| Infection |
1.5% |
| Interstitial Lung Disease |
1.5% |
| Ventricular Septal Defect |
1.5% |
| Coagulopathy |
1.0% |
| Infection Prophylaxis |
1.0% |
| Ischaemia |
1.0% |
| Sclerodactylia |
1.0% |
| Atrial Fibrillation |
0.8% |
| Cardiac Failure |
0.8% |
|
| Sepsis |
17.2% |
| Liver Disorder |
9.7% |
| Pulmonary Hypertension |
7.5% |
| Platelet Count Decreased |
6.5% |
| Pulmonary Oedema |
6.5% |
| Tricuspid Valve Incompetence |
6.5% |
| Unresponsive To Stimuli |
6.5% |
| Death |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Vitreous Haemorrhage |
4.3% |
| Cardiac Failure |
3.2% |
| Drug Interaction |
3.2% |
| Hypoxia |
3.2% |
| Urticaria |
3.2% |
| Vomiting |
3.2% |
| Hypertransaminasaemia |
2.2% |
| Hypoaesthesia |
2.2% |
| Pericardial Effusion |
2.2% |
| Pneumonia |
2.2% |
| Right Ventricular Failure |
2.2% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
26.1% |
| Pulmonary Hypertension |
25.7% |
| Drug Use For Unknown Indication |
13.0% |
| Product Used For Unknown Indication |
12.4% |
| Systemic Lupus Erythematosus |
5.9% |
| Oedema |
2.2% |
| Hypertension |
2.0% |
| Rheumatoid Arthritis |
1.4% |
| Scleroderma |
1.4% |
| Depression |
1.2% |
| Fibrinous Bronchitis |
1.2% |
| Osteoporosis |
1.1% |
| Hepatitis C |
0.9% |
| Hypothyroidism |
0.9% |
| Pulmonary Embolism |
0.9% |
| Anaemia |
0.8% |
| Mixed Connective Tissue Disease |
0.8% |
| Anticoagulant Therapy |
0.7% |
| Anxiety |
0.7% |
| Asthma |
0.7% |
|
| Right Ventricular Failure |
10.6% |
| Pulmonary Hypertension |
9.1% |
| Visual Acuity Reduced |
8.3% |
| Vomiting |
8.3% |
| Pulmonary Arterial Hypertension |
6.1% |
| Death |
5.3% |
| Respiratory Failure |
5.3% |
| Pneumonia |
4.5% |
| Progressive Multifocal Leukoencephalopathy |
4.5% |
| Dyspnoea |
3.8% |
| Renal Failure Acute |
3.8% |
| Supraventricular Tachycardia |
3.8% |
| Tremor |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
| Drug Ineffective |
3.0% |
| Fatigue |
3.0% |
| Osteonecrosis |
3.0% |
| Subdural Haematoma |
3.0% |
| Thrombocytopenia |
3.0% |
|
| Interacting |
| Pulmonary Arterial Hypertension |
29.2% |
| Hepatitis C |
12.5% |
| Chronic Obstructive Pulmonary Disease |
8.3% |
| Contraception |
8.3% |
| Endocarditis |
8.3% |
| Hepatitis B |
8.3% |
| Hiv Infection |
8.3% |
| Superinfection |
8.3% |
| Arthropathy |
4.2% |
| Pulmonary Hypertension |
4.2% |
|
| Liver Disorder |
18.2% |
| Liver Injury |
18.2% |
| Unintended Pregnancy |
18.2% |
| Hepatotoxicity |
9.1% |
| Off Label Use |
9.1% |
| Pulmonary Arterial Pressure Increased |
9.1% |
| Thrombocytopenia |
9.1% |
| White Blood Cell Count Decreased |
9.1% |
|
